We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Neurology

Redefining CTE: New Autopsy Evidence Links Repetitive Head Impact to Extensive Spinal Cord Pathology

MedXY Editorial Team•Feb 10, 2026•Neurology
CTEneurodegenerationSpinal Cord PathologyTauopathy

Introduction: Expanding the Boundaries of Chronic Traumatic Encephalopathy

The medical understanding of Chronic Traumatic Encephalopathy (CTE) has traditionally focused on the cerebral cortex, specifically the pathognomonic accumulation of hyperphosphorylated tau (p-tau) in neurons and astrocytes around small blood vessels at the depths of the cortical sulci. However, emerging clinical evidence suggests that individuals exposed to repetitive head impacts (RHI) often present with a constellation of symptoms that extend beyond cognitive and behavioral changes, frequently involving motor dysfunction reminiscent of amyotrophic lateral sclerosis (ALS) or parkinsonism. A groundbreaking study by Tanaka et al., published in JAMA Neurology (2026), provides critical evidence that the pathology of CTE is not confined to the brain but represents a systemic trauma-related encephalomyelopathy involving the spinal cord.

The Clinical Imperative

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Smoking, Exhaled Carbon Monoxide, and Parkinson’s Disease Risk: Epidemiological Insights and Mechanistic PerspectivesThis review explores evidence linking smoking and exhaled carbon monoxide levels to reduced Parkinson’s disease risk, emphasizing a potential protective role of carbon monoxide, supported by recent large-scale cohort data and biologicSep 12, 2026Unraveling White Matter Hyperintensities: Distinct Lesion Subtypes Reveal Diverse Clinical Implications Beyond LocationAdvanced MRI analyses identify three biologically distinct subtypes of white matter hyperintensities (WMHs), linking specific lesion evolution patterns with neurodegeneration and vascular/metabolic risks, offering refined insights into cereAug 29, 2026Serum Ferritin and Inflammation in Isolated REM Sleep Behavior Disorder: Insights from Longitudinal Cohort StudiesThis review explores the role of dysregulated iron metabolism and inflammation, particularly elevated serum ferritin, in isolated REM sleep behavior disorder (iRBD) as a prodromal stage of neurodegeneration, synthesizing recent longitudinalAug 6, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Automated Speech Analysis in Primary Progressive Aphasia: Diagnostic, Anatomical, and Pathological Insights
Automated speech analysis of brief connected speech accurately identifies clinical, anatomical, and neuropathological variants of primary progressive aphasia, facilitating scalable diagnosis and monitoring.
Aug 6, 2026
Survival Estimates and Predictors in Genetic Frontotemporal Dementia: Insights from an International Retrospective Cohort StudyThis review synthesizes international evidence on survival in genetic frontotemporal dementia (FTD), highlighting key predictors such as age at onset, clinical phenotype, and motor symptoms, and discusses implications for patient care and tAug 5, 2026
Decoding Tofersen’s CNS Penetrance and Efficacy in SOD1-ALS Through Autopsy Tissue AnalysisThis study unveils tofersen’s distribution and potent SOD1 reduction within the CNS of SOD1-ALS patients, utilizing autopsy tissues from clinical trial participants, confirming anticipated pharmacokinetic and pharmacodynamic effects.Jul 8, 2026